These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29845536)
21. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses. Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394 [TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017. Perng GC; Ho TC; Shih HI; Lee CH; Huang PW; Chung CH; Ko NY; Ko WC; Chien YW Emerg Infect Dis; 2019 Apr; 25(4):814-816. PubMed ID: 30882327 [TBL] [Abstract][Full Text] [Related]
23. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice. Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607 [TBL] [Abstract][Full Text] [Related]
31. Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace? Martín-Acebes MA; Saiz JC; Jiménez de Oya N Front Cell Infect Microbiol; 2018; 8():44. PubMed ID: 29497604 [No Abstract] [Full Text] [Related]
32. Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection. Hassert M; Steffen TL; Scroggins S; Coleman AK; Shacham E; Brien JD; Pinto AK J Virol; 2021 Jul; 95(16):e0057321. PubMed ID: 34076486 [TBL] [Abstract][Full Text] [Related]
33. A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. Prow NA; Liu L; Nakayama E; Cooper TH; Yan K; Eldi P; Hazlewood JE; Tang B; Le TT; Setoh YX; Khromykh AA; Hobson-Peters J; Diener KR; Howley PM; Hayball JD; Suhrbier A Nat Commun; 2018 Mar; 9(1):1230. PubMed ID: 29581442 [TBL] [Abstract][Full Text] [Related]
34. Use of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections. Tsai WY; Youn HH; Tyson J; Brites C; Tsai JJ; Pedroso C; Drexler JF; Balmaseda A; Harris E; Wang WK Emerg Infect Dis; 2018 Jul; 24(7):1355-1359. PubMed ID: 29912689 [TBL] [Abstract][Full Text] [Related]
35. Zika Virus Molecular Biology and Perspectives for Vaccine Development: A Review. Lin HH; Huang LM; Wu SC J Nurs Res; 2017 Feb; 25(1):3-6. PubMed ID: 28072676 [No Abstract] [Full Text] [Related]
36. A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection. Shi X; Hu J; Guo J; Wu C; Xiong S; Dong C Virol Sin; 2019 Feb; 34(1):106-110. PubMed ID: 30820837 [No Abstract] [Full Text] [Related]
37. Dengue and other flavivirus infections. Choumet V; Desprès P Rev Sci Tech; 2015 Aug; 34(2):473-8, 467-72. PubMed ID: 26601449 [TBL] [Abstract][Full Text] [Related]
38. Sertoli Cells Are Susceptible to ZIKV Infection in Mouse Testis. Sheng ZY; Gao N; Wang ZY; Cui XY; Zhou DS; Fan DY; Chen H; Wang PG; An J Front Cell Infect Microbiol; 2017; 7():272. PubMed ID: 28680856 [TBL] [Abstract][Full Text] [Related]
39. The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis. Heinz FX; Stiasny K Microbiol Mol Biol Rev; 2017 Mar; 81(1):. PubMed ID: 28179396 [TBL] [Abstract][Full Text] [Related]